S
Shuxin Sun
Researcher at Sun Yat-sen University
Publications - 21
Citations - 270
Shuxin Sun is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Irreversible electroporation & Cancer. The author has an hindex of 5, co-authored 18 publications receiving 120 citations.
Papers
More filters
Journal ArticleDOI
Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
TL;DR: The alteration of CD8+ T cell between D3 and D7 showed relatively good performance and could be used as an effective tool for prognostic evaluation for LAPC patients after IRE, the first evidence of IRE-based immunomodulatory in patients with LapC.
Journal ArticleDOI
Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma.
Xin Huang,Chaobin He,Xin Hua,Anna Kan,Yize Mao,Shuxin Sun,Fangting Duan,Jun Wang,Peng Huang,Shengping Li +9 more
TL;DR: Oxidative stress in the tumor microenvironment could induce MMT in PDAC, thus inducing reactive stroma, modulating immunosuppression, and promoting tumor progression, and reducing oxidative stress may be a promising future therapeutic regimen.
Journal ArticleDOI
Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
TL;DR: Induction chemotherapy followed by IRE is superior to induction chemotherapy following by radiotherapy for treating LAPC and a randomized clinical trial comparing the efficacy of IRE and radiotherapy after the induction chemotherapy is considerable.
Journal ArticleDOI
The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer.
TL;DR: In this paper, reversible electroporation was used to induce macrophage polarization induced by activating the MAPK-p38 pathway and increasing the expression of M1 markers in macrophages, through binding to the advanced glycation endproduct (RAGE) receptor.
Journal ArticleDOI
Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer.
Shuxin Sun,Yang Liu,Chaobin He,Wanming Hu,Wenfeng Liu,Xin Huang,Jiali Wu,Fengxiao Xie,Chen Chen,Jun Wang,Yuan Lin,Wenbo Zhu,Guangmei Yan,Jing Cai,Shengping Li +14 more
TL;DR: It was shown that IRE triggered reactive oxygen species (ROS)-dependent apoptosis in pancreatic cancer cells (PCCs) mediated by phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) pathway suppression and when NanoKnife was combined with M1 virus, the therapeutic efficacy was synergistically enhanced.